Hvivo (HVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 May 2012 07:00 AM
RNS
Notification of Major Interest in Shares
16 May 2012 07:00 AM
RNS
Notification of Major Interest in Shares
10 May 2012 04:42 PM
RNS
Notification of Major Interest in Shares
10 May 2012 02:00 PM
RNS
Contract Win
10 May 2012 07:00 AM
RNS
Notification of Major Interest in Shares
09 May 2012 07:00 AM
RNS
Notification of Major Interest in Shares
09 May 2012 07:00 AM
RNS
Notification of Major Interest in Shares
08 May 2012 04:48 PM
RNS
Notification of Major Interest in Shares
03 May 2012 07:00 AM
RNS
First day of Dealings and Admission to AIM

hVIVO is a contract research organization that conducts human challenge clinical trials for respiratory and infectious disease vaccines and therapeutics:

hVIVO offers services such as challenge trials, assay development, field trial bio-logistics, cell based assays, molecular services, compound efficacy and VRM, and biomarker analysis.

Formerly known as Retroscreen, hVIVO was renamed in 2015 when it went public on the London Stock Exchange.

hVIVO has a portfolio of 11 human challenge models, with more models in development. Their portfolio includes models for influenza, respiratory syncytial virus, human rhinovirus, asthma, COPD, cough, malaria, COVID-19, and hMPV.

hVIVO share price launched at 33p in 2012.

UK 100

Latest directors dealings